Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risperidone vs Cariprazine in Acute Mania a Head to Head Comparison of Efficacy vs Tolerability

NCT07665073 is registered in ClinicalTrials.gov with Pakistan Institute of Medical Sciences as lead sponsor.

NCT NCT07665073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07665073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risperidone vs Cariprazine in Acute Mania a Head to Head Comparison of Efficacy vs Tolerability
Lead sponsor
Pakistan Institute of Medical Sciences
Phase
Phase 4
Overall status
Not yet recruiting
Start date
June 30, 2027
Completion date
June 30, 2028
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar 1 disorder